A randomized, placebo-controlled, double-blind, parallel design phase 2 dose ranging trial to assess the safety and efficacy of DA-8159 [udenafil] tablets in male subjects with erectile dysfunction.
Phase of Trial: Phase II
Latest Information Update: 24 Mar 2009
At a glance
- Drugs Udenafil (Primary)
- Indications Erectile dysfunction
- Focus Adverse reactions; Therapeutic Use
- Sponsors Dong-A Pharmaceutical
- 21 May 2007 New trial record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History